Efficacy and Safety of HRS9531 in Participants With Type 2 Diabetes Treated With Basal Insulin

Clinical trial NCT07060456 · RECRUITING

Trial details

NCT number: NCT07060456
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2025-07-25
Primary completion: 2027-02-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.